Financial News

Financial Report: AMRI

Contract revenue up 52% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AMRI   4Q Revenues: $126.4 million (+46%)   4Q Earnings: $1.8 million (loss of $1.9 million 4Q14)   FY Revenues: $402.3 million (+45%)   FY Loss: $2.3 million (loss of $3.3 million FY14)   Comments: Contract revenue for the quarter was $123.0 million, up 52%. Margins benefited from recent acquisitions, product mix within the Drug Product segment and the impact of cost reduction initiatives and facility optimization activities. Royalty revenue in the quarter was $3.4 million, down 43% d...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters